. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Clinical Trials, Phase III as TopicColorectal Neoplasms/drug therapyColorectal Neoplasms/pathologyDrug ApprovalHumansLiver Neoplasms/drug therapyLiver Neoplasms/secondaryMulticenter Studies as TopicPrognosisRandomized Controlled Trials as TopicReceptors, Vascular Endothelial Growth FactorRecombinant Fusion Proteins/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances: See more » Recombinant Fusion ProteinsafliberceptReceptors, Vascular Endothelial Growth Factor
Year: 2012 PMID: 23061342
Source DB: PubMed Journal: Oncology (Williston Park) ISSN: 0890-9091 Impact factor: 2.990